Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

about

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

Item

http://www.wikidata.org/entity/Q46237277

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

@en

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

@nl

type

Item

label

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

@en

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

@nl

prefLabel

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

@en

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

@nl

P1476

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

@en

P2093

Bhumasamudram Jagadish

http://www.w3.org/2001/XMLSchema#string

Bryan Oronsky

http://www.w3.org/2001/XMLSchema#string

Elizabeth Bruckheimer

http://www.w3.org/2001/XMLSchema#string

Eugene A Mash

http://www.w3.org/2001/XMLSchema#string

Gerald P Guntle

http://www.w3.org/2001/XMLSchema#string

Jan Scicinski

http://www.w3.org/2001/XMLSchema#string

Natarajan Raghunand

http://www.w3.org/2001/XMLSchema#string

Ronald L Korn

http://www.w3.org/2001/XMLSchema#string

P2860

NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001

Rewriting the epigenetic code for tumor resensitization: a review.

Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.

Development of methods for the bioanalysis of RRx-001 and metabolites.

Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent.

Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm

Redox-active magnetic resonance imaging contrast agents: studies with thiol-bearing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid derivatives.

Angiogenesis and vascular targeting in Ewing sarcoma: a review of preclinical and clinical data.

Targeting Glutathione S-transferase M4 in Ewing sarcoma

Episensitization: therapeutic tumor resensitization by epigenetic agents: a review and reassessment.

P304

102511-102520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18455

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29254266

http://www.w3.org/2001/XMLSchema#string

P932

5731976

http://www.w3.org/2001/XMLSchema#string